Analysts say the adoption of GLP-1 drugs, the expansion of AI and the growth of multi-billion-dollar M&A deals chart an unpredictable path for the industry this year.
The snacking giant secured licensing deals in the frozen aisle for two staple brands, and Graeter’s Ice Cream partnered with ...